nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—ABCB1—lung cancer	0.209	1	CbGaD
Fexofenadine—SLCO2B1—Erlotinib—lung cancer	0.0924	0.152	CbGbCtD
Fexofenadine—SLCO1B3—Paclitaxel—lung cancer	0.0751	0.124	CbGbCtD
Fexofenadine—SLCO1B3—Docetaxel—lung cancer	0.0543	0.0896	CbGbCtD
Fexofenadine—SLCO1B1—Irinotecan—lung cancer	0.0431	0.0712	CbGbCtD
Fexofenadine—SLCO1B3—Methotrexate—lung cancer	0.0392	0.0647	CbGbCtD
Fexofenadine—ABCB1—Topotecan—lung cancer	0.0253	0.0418	CbGbCtD
Fexofenadine—SLCO1A2—Methotrexate—lung cancer	0.0242	0.04	CbGbCtD
Fexofenadine—ABCB1—Gefitinib—lung cancer	0.0231	0.0382	CbGbCtD
Fexofenadine—SLCO1B1—Methotrexate—lung cancer	0.0228	0.0377	CbGbCtD
Fexofenadine—CYP2D6—Gefitinib—lung cancer	0.0218	0.036	CbGbCtD
Fexofenadine—ABCB1—Vinorelbine—lung cancer	0.0178	0.0294	CbGbCtD
Fexofenadine—CYP2D6—Vinorelbine—lung cancer	0.0168	0.0277	CbGbCtD
Fexofenadine—ABCB1—Crizotinib—lung cancer	0.0142	0.0234	CbGbCtD
Fexofenadine—ABCB1—Gemcitabine—lung cancer	0.0139	0.0229	CbGbCtD
Fexofenadine—ABCB1—Erlotinib—lung cancer	0.0137	0.0226	CbGbCtD
Fexofenadine—CYP2D6—Erlotinib—lung cancer	0.0129	0.0213	CbGbCtD
Fexofenadine—ABCB1—Paclitaxel—lung cancer	0.0125	0.0207	CbGbCtD
Fexofenadine—ABCB1—Irinotecan—lung cancer	0.0124	0.0204	CbGbCtD
Fexofenadine—ABCB1—Vinblastine—lung cancer	0.011	0.0181	CbGbCtD
Fexofenadine—CYP2D6—Vinblastine—lung cancer	0.0104	0.0171	CbGbCtD
Fexofenadine—ABCB1—Cisplatin—lung cancer	0.0101	0.0166	CbGbCtD
Fexofenadine—ABCB1—Etoposide—lung cancer	0.0099	0.0163	CbGbCtD
Fexofenadine—ABCB1—Docetaxel—lung cancer	0.00905	0.015	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—lung cancer	0.00675	0.0111	CbGbCtD
Fexofenadine—ABCB1—Methotrexate—lung cancer	0.00654	0.0108	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—lung cancer	0.00636	0.0105	CbGbCtD
Fexofenadine—Loperamide—POMC—lung cancer	0.000941	0.446	CrCbGaD
Fexofenadine—Lomitapide—ABCB1—lung cancer	0.000471	0.223	CrCbGaD
Fexofenadine—Pimozide—CYP2E1—lung cancer	0.000256	0.121	CrCbGaD
Fexofenadine—Asthenia—Erlotinib—lung cancer	0.00024	0.00211	CcSEcCtD
Fexofenadine—Pruritus—Topotecan—lung cancer	0.000239	0.00211	CcSEcCtD
Fexofenadine—Anaphylactic shock—Irinotecan—lung cancer	0.000238	0.0021	CcSEcCtD
Fexofenadine—Diarrhoea—Vinblastine—lung cancer	0.000238	0.0021	CcSEcCtD
Fexofenadine—Infection—Irinotecan—lung cancer	0.000237	0.00209	CcSEcCtD
Fexofenadine—Pruritus—Erlotinib—lung cancer	0.000236	0.00208	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000236	0.00208	CcSEcCtD
Fexofenadine—Back pain—Etoposide—lung cancer	0.000235	0.00207	CcSEcCtD
Fexofenadine—Flatulence—Paclitaxel—lung cancer	0.000235	0.00207	CcSEcCtD
Fexofenadine—Tension—Paclitaxel—lung cancer	0.000234	0.00206	CcSEcCtD
Fexofenadine—Anaphylactic shock—Gemcitabine—lung cancer	0.000232	0.00205	CcSEcCtD
Fexofenadine—Nervousness—Paclitaxel—lung cancer	0.000231	0.00204	CcSEcCtD
Fexofenadine—Diarrhoea—Topotecan—lung cancer	0.000231	0.00204	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—lung cancer	0.000231	0.00203	CcSEcCtD
Fexofenadine—Infection—Gemcitabine—lung cancer	0.000231	0.00203	CcSEcCtD
Fexofenadine—Back pain—Paclitaxel—lung cancer	0.00023	0.00203	CcSEcCtD
Fexofenadine—Dizziness—Vinblastine—lung cancer	0.00023	0.00203	CcSEcCtD
Fexofenadine—Urticaria—Vinorelbine—lung cancer	0.00023	0.00202	CcSEcCtD
Fexofenadine—Diarrhoea—Erlotinib—lung cancer	0.000229	0.00201	CcSEcCtD
Fexofenadine—Abdominal pain—Vinorelbine—lung cancer	0.000228	0.00201	CcSEcCtD
Fexofenadine—Body temperature increased—Vinorelbine—lung cancer	0.000228	0.00201	CcSEcCtD
Fexofenadine—Myalgia—Cisplatin—lung cancer	0.000226	0.00199	CcSEcCtD
Fexofenadine—Vision blurred—Paclitaxel—lung cancer	0.000224	0.00198	CcSEcCtD
Fexofenadine—Dizziness—Topotecan—lung cancer	0.000223	0.00197	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—lung cancer	0.000223	0.00196	CcSEcCtD
Fexofenadine—Vomiting—Vinblastine—lung cancer	0.000221	0.00195	CcSEcCtD
Fexofenadine—Dizziness—Erlotinib—lung cancer	0.000221	0.00195	CcSEcCtD
Fexofenadine—Agitation—Paclitaxel—lung cancer	0.000219	0.00193	CcSEcCtD
Fexofenadine—Headache—Vinblastine—lung cancer	0.000218	0.00192	CcSEcCtD
Fexofenadine—Angioedema—Paclitaxel—lung cancer	0.000218	0.00192	CcSEcCtD
Fexofenadine—Anaphylactic shock—Cisplatin—lung cancer	0.000216	0.00191	CcSEcCtD
Fexofenadine—Insomnia—Irinotecan—lung cancer	0.000216	0.0019	CcSEcCtD
Fexofenadine—Flushing—Docetaxel—lung cancer	0.000215	0.0019	CcSEcCtD
Fexofenadine—Infection—Cisplatin—lung cancer	0.000215	0.00189	CcSEcCtD
Fexofenadine—Vomiting—Topotecan—lung cancer	0.000215	0.00189	CcSEcCtD
Fexofenadine—Rash—Topotecan—lung cancer	0.000213	0.00188	CcSEcCtD
Fexofenadine—Hypersensitivity—Vinorelbine—lung cancer	0.000213	0.00188	CcSEcCtD
Fexofenadine—Dermatitis—Topotecan—lung cancer	0.000213	0.00188	CcSEcCtD
Fexofenadine—Vomiting—Erlotinib—lung cancer	0.000212	0.00187	CcSEcCtD
Fexofenadine—Dyspnoea—Irinotecan—lung cancer	0.000212	0.00187	CcSEcCtD
Fexofenadine—Cough—Etoposide—lung cancer	0.000212	0.00187	CcSEcCtD
Fexofenadine—Somnolence—Irinotecan—lung cancer	0.000212	0.00187	CcSEcCtD
Fexofenadine—Headache—Topotecan—lung cancer	0.000212	0.00186	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000211	0.00186	CcSEcCtD
Fexofenadine—Tachycardia—Cisplatin—lung cancer	0.000211	0.00186	CcSEcCtD
Fexofenadine—Rash—Erlotinib—lung cancer	0.000211	0.00186	CcSEcCtD
Fexofenadine—Dermatitis—Erlotinib—lung cancer	0.00021	0.00186	CcSEcCtD
Fexofenadine—Palpitations—Paclitaxel—lung cancer	0.00021	0.00185	CcSEcCtD
Fexofenadine—Insomnia—Gemcitabine—lung cancer	0.00021	0.00185	CcSEcCtD
Fexofenadine—Dyspepsia—Irinotecan—lung cancer	0.00021	0.00185	CcSEcCtD
Fexofenadine—Headache—Erlotinib—lung cancer	0.000209	0.00184	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—lung cancer	0.000209	0.00184	CcSEcCtD
Fexofenadine—Cough—Paclitaxel—lung cancer	0.000208	0.00183	CcSEcCtD
Fexofenadine—Asthenia—Vinorelbine—lung cancer	0.000207	0.00183	CcSEcCtD
Fexofenadine—Dyspnoea—Gemcitabine—lung cancer	0.000207	0.00182	CcSEcCtD
Fexofenadine—Nausea—Vinblastine—lung cancer	0.000206	0.00182	CcSEcCtD
Fexofenadine—Somnolence—Gemcitabine—lung cancer	0.000206	0.00182	CcSEcCtD
Fexofenadine—Fatigue—Irinotecan—lung cancer	0.000205	0.00181	CcSEcCtD
Fexofenadine—Pruritus—Vinorelbine—lung cancer	0.000204	0.0018	CcSEcCtD
Fexofenadine—Pain—Irinotecan—lung cancer	0.000204	0.0018	CcSEcCtD
Fexofenadine—Myalgia—Paclitaxel—lung cancer	0.000203	0.00179	CcSEcCtD
Fexofenadine—Nausea—Topotecan—lung cancer	0.000201	0.00177	CcSEcCtD
Fexofenadine—Abdominal discomfort—Methotrexate—lung cancer	0.0002	0.00176	CcSEcCtD
Fexofenadine—Fatigue—Gemcitabine—lung cancer	0.0002	0.00176	CcSEcCtD
Fexofenadine—Pain—Gemcitabine—lung cancer	0.000198	0.00175	CcSEcCtD
Fexofenadine—Nausea—Erlotinib—lung cancer	0.000198	0.00175	CcSEcCtD
Fexofenadine—Dry mouth—Paclitaxel—lung cancer	0.000198	0.00175	CcSEcCtD
Fexofenadine—Anaphylactic shock—Etoposide—lung cancer	0.000198	0.00175	CcSEcCtD
Fexofenadine—Diarrhoea—Vinorelbine—lung cancer	0.000198	0.00174	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000197	0.00174	CcSEcCtD
Fexofenadine—Infection—Etoposide—lung cancer	0.000197	0.00174	CcSEcCtD
Fexofenadine—Back pain—Docetaxel—lung cancer	0.000195	0.00172	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Irinotecan—lung cancer	0.000195	0.00172	CcSEcCtD
Fexofenadine—Anaphylactic shock—Paclitaxel—lung cancer	0.000194	0.00171	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Methotrexate—lung cancer	0.000194	0.00171	CcSEcCtD
Fexofenadine—Tachycardia—Etoposide—lung cancer	0.000193	0.0017	CcSEcCtD
Fexofenadine—Infection—Paclitaxel—lung cancer	0.000193	0.0017	CcSEcCtD
Fexofenadine—Dyspnoea—Cisplatin—lung cancer	0.000193	0.0017	CcSEcCtD
Fexofenadine—Dizziness—Vinorelbine—lung cancer	0.000191	0.00168	CcSEcCtD
Fexofenadine—Tachycardia—Paclitaxel—lung cancer	0.00019	0.00167	CcSEcCtD
Fexofenadine—Body temperature increased—Irinotecan—lung cancer	0.000188	0.00166	CcSEcCtD
Fexofenadine—Abdominal pain—Irinotecan—lung cancer	0.000188	0.00166	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—lung cancer	0.000187	0.00165	CcSEcCtD
Fexofenadine—Drowsiness—Methotrexate—lung cancer	0.000186	0.00164	CcSEcCtD
Fexofenadine—Pain—Cisplatin—lung cancer	0.000185	0.00163	CcSEcCtD
Fexofenadine—Vomiting—Vinorelbine—lung cancer	0.000184	0.00162	CcSEcCtD
Fexofenadine—Body temperature increased—Gemcitabine—lung cancer	0.000183	0.00162	CcSEcCtD
Fexofenadine—Rash—Vinorelbine—lung cancer	0.000182	0.00161	CcSEcCtD
Fexofenadine—Dermatitis—Vinorelbine—lung cancer	0.000182	0.0016	CcSEcCtD
Fexofenadine—Headache—Vinorelbine—lung cancer	0.000181	0.0016	CcSEcCtD
Fexofenadine—Palpitations—Docetaxel—lung cancer	0.000178	0.00157	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000177	0.00156	CcSEcCtD
Fexofenadine—Dyspnoea—Etoposide—lung cancer	0.000177	0.00156	CcSEcCtD
Fexofenadine—Somnolence—Etoposide—lung cancer	0.000176	0.00155	CcSEcCtD
Fexofenadine—Cough—Docetaxel—lung cancer	0.000176	0.00155	CcSEcCtD
Fexofenadine—Insomnia—Paclitaxel—lung cancer	0.000176	0.00155	CcSEcCtD
Fexofenadine—Epistaxis—Methotrexate—lung cancer	0.000176	0.00155	CcSEcCtD
Fexofenadine—Hypersensitivity—Irinotecan—lung cancer	0.000176	0.00155	CcSEcCtD
Fexofenadine—Dyspnoea—Paclitaxel—lung cancer	0.000173	0.00153	CcSEcCtD
Fexofenadine—Somnolence—Paclitaxel—lung cancer	0.000173	0.00152	CcSEcCtD
Fexofenadine—Myalgia—Docetaxel—lung cancer	0.000172	0.00151	CcSEcCtD
Fexofenadine—Nausea—Vinorelbine—lung cancer	0.000172	0.00151	CcSEcCtD
Fexofenadine—Dyspepsia—Paclitaxel—lung cancer	0.000171	0.00151	CcSEcCtD
Fexofenadine—Body temperature increased—Cisplatin—lung cancer	0.000171	0.00151	CcSEcCtD
Fexofenadine—Asthenia—Irinotecan—lung cancer	0.000171	0.00151	CcSEcCtD
Fexofenadine—Fatigue—Etoposide—lung cancer	0.000171	0.00151	CcSEcCtD
Fexofenadine—Pain—Etoposide—lung cancer	0.000169	0.00149	CcSEcCtD
Fexofenadine—Dry mouth—Docetaxel—lung cancer	0.000168	0.00148	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000168	0.00148	CcSEcCtD
Fexofenadine—Fatigue—Paclitaxel—lung cancer	0.000168	0.00148	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—lung cancer	0.000167	0.00147	CcSEcCtD
Fexofenadine—Asthenia—Gemcitabine—lung cancer	0.000167	0.00147	CcSEcCtD
Fexofenadine—Pain—Paclitaxel—lung cancer	0.000166	0.00146	CcSEcCtD
Fexofenadine—Anaphylactic shock—Docetaxel—lung cancer	0.000165	0.00145	CcSEcCtD
Fexofenadine—Pruritus—Gemcitabine—lung cancer	0.000164	0.00145	CcSEcCtD
Fexofenadine—Infection—Docetaxel—lung cancer	0.000164	0.00144	CcSEcCtD
Fexofenadine—Diarrhoea—Irinotecan—lung cancer	0.000163	0.00144	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Etoposide—lung cancer	0.000162	0.00143	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—lung cancer	0.000161	0.00142	CcSEcCtD
Fexofenadine—Tachycardia—Docetaxel—lung cancer	0.000161	0.00142	CcSEcCtD
Fexofenadine—Hypersensitivity—Cisplatin—lung cancer	0.000159	0.0014	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000159	0.0014	CcSEcCtD
Fexofenadine—Diarrhoea—Gemcitabine—lung cancer	0.000159	0.0014	CcSEcCtD
Fexofenadine—Dizziness—Irinotecan—lung cancer	0.000158	0.00139	CcSEcCtD
Fexofenadine—Urticaria—Etoposide—lung cancer	0.000157	0.00139	CcSEcCtD
Fexofenadine—Body temperature increased—Etoposide—lung cancer	0.000157	0.00138	CcSEcCtD
Fexofenadine—Abdominal pain—Etoposide—lung cancer	0.000157	0.00138	CcSEcCtD
Fexofenadine—Asthenia—Cisplatin—lung cancer	0.000155	0.00137	CcSEcCtD
Fexofenadine—Urticaria—Paclitaxel—lung cancer	0.000154	0.00136	CcSEcCtD
Fexofenadine—Body temperature increased—Paclitaxel—lung cancer	0.000154	0.00135	CcSEcCtD
Fexofenadine—Abdominal pain—Paclitaxel—lung cancer	0.000154	0.00135	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—lung cancer	0.000152	0.00134	CcSEcCtD
Fexofenadine—Vomiting—Irinotecan—lung cancer	0.000151	0.00134	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—lung cancer	0.000151	0.00133	CcSEcCtD
Fexofenadine—Rash—Irinotecan—lung cancer	0.00015	0.00132	CcSEcCtD
Fexofenadine—Dermatitis—Irinotecan—lung cancer	0.00015	0.00132	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00015	0.00132	CcSEcCtD
Fexofenadine—Headache—Irinotecan—lung cancer	0.000149	0.00132	CcSEcCtD
Fexofenadine—Insomnia—Docetaxel—lung cancer	0.000149	0.00131	CcSEcCtD
Fexofenadine—Diarrhoea—Cisplatin—lung cancer	0.000148	0.0013	CcSEcCtD
Fexofenadine—Vomiting—Gemcitabine—lung cancer	0.000148	0.0013	CcSEcCtD
Fexofenadine—Dyspnoea—Docetaxel—lung cancer	0.000147	0.00129	CcSEcCtD
Fexofenadine—Somnolence—Docetaxel—lung cancer	0.000146	0.00129	CcSEcCtD
Fexofenadine—Rash—Gemcitabine—lung cancer	0.000146	0.00129	CcSEcCtD
Fexofenadine—Dermatitis—Gemcitabine—lung cancer	0.000146	0.00129	CcSEcCtD
Fexofenadine—Hypersensitivity—Etoposide—lung cancer	0.000146	0.00129	CcSEcCtD
Fexofenadine—Headache—Gemcitabine—lung cancer	0.000145	0.00128	CcSEcCtD
Fexofenadine—Dyspepsia—Docetaxel—lung cancer	0.000145	0.00128	CcSEcCtD
Fexofenadine—Hypersensitivity—Paclitaxel—lung cancer	0.000143	0.00126	CcSEcCtD
Fexofenadine—Asthenia—Etoposide—lung cancer	0.000142	0.00125	CcSEcCtD
Fexofenadine—Fatigue—Docetaxel—lung cancer	0.000142	0.00125	CcSEcCtD
Fexofenadine—Nausea—Irinotecan—lung cancer	0.000142	0.00125	CcSEcCtD
Fexofenadine—Pain—Docetaxel—lung cancer	0.000141	0.00124	CcSEcCtD
Fexofenadine—Back pain—Methotrexate—lung cancer	0.000141	0.00124	CcSEcCtD
Fexofenadine—Pruritus—Etoposide—lung cancer	0.00014	0.00124	CcSEcCtD
Fexofenadine—Asthenia—Paclitaxel—lung cancer	0.000139	0.00123	CcSEcCtD
Fexofenadine—Nausea—Gemcitabine—lung cancer	0.000138	0.00122	CcSEcCtD
Fexofenadine—Vomiting—Cisplatin—lung cancer	0.000138	0.00121	CcSEcCtD
Fexofenadine—Pruritus—Paclitaxel—lung cancer	0.000137	0.00121	CcSEcCtD
Fexofenadine—Vision blurred—Methotrexate—lung cancer	0.000137	0.00121	CcSEcCtD
Fexofenadine—Rash—Cisplatin—lung cancer	0.000136	0.0012	CcSEcCtD
Fexofenadine—Dermatitis—Cisplatin—lung cancer	0.000136	0.0012	CcSEcCtD
Fexofenadine—Diarrhoea—Etoposide—lung cancer	0.000136	0.0012	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Docetaxel—lung cancer	0.000135	0.00119	CcSEcCtD
Fexofenadine—Pimozide—ABCB1—lung cancer	0.000134	0.0636	CrCbGaD
Fexofenadine—Flushing—Doxorubicin—lung cancer	0.000134	0.00118	CcSEcCtD
Fexofenadine—Diarrhoea—Paclitaxel—lung cancer	0.000133	0.00117	CcSEcCtD
Fexofenadine—Dizziness—Etoposide—lung cancer	0.000131	0.00116	CcSEcCtD
Fexofenadine—Abdominal pain—Docetaxel—lung cancer	0.00013	0.00115	CcSEcCtD
Fexofenadine—Body temperature increased—Docetaxel—lung cancer	0.00013	0.00115	CcSEcCtD
Fexofenadine—Dizziness—Paclitaxel—lung cancer	0.000128	0.00113	CcSEcCtD
Fexofenadine—Nausea—Cisplatin—lung cancer	0.000128	0.00113	CcSEcCtD
Fexofenadine—Cough—Methotrexate—lung cancer	0.000127	0.00112	CcSEcCtD
Fexofenadine—Vomiting—Etoposide—lung cancer	0.000126	0.00111	CcSEcCtD
Fexofenadine—Rash—Etoposide—lung cancer	0.000125	0.0011	CcSEcCtD
Fexofenadine—Dermatitis—Etoposide—lung cancer	0.000125	0.0011	CcSEcCtD
Fexofenadine—Headache—Etoposide—lung cancer	0.000124	0.00109	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—lung cancer	0.000124	0.00109	CcSEcCtD
Fexofenadine—Myalgia—Methotrexate—lung cancer	0.000124	0.00109	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—lung cancer	0.000124	0.00109	CcSEcCtD
Fexofenadine—Vomiting—Paclitaxel—lung cancer	0.000124	0.00109	CcSEcCtD
Fexofenadine—Rash—Paclitaxel—lung cancer	0.000123	0.00108	CcSEcCtD
Fexofenadine—Dermatitis—Paclitaxel—lung cancer	0.000122	0.00108	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—lung cancer	0.000122	0.00108	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—lung cancer	0.000122	0.00107	CcSEcCtD
Fexofenadine—Headache—Paclitaxel—lung cancer	0.000122	0.00107	CcSEcCtD
Fexofenadine—Hypersensitivity—Docetaxel—lung cancer	0.000121	0.00107	CcSEcCtD
Fexofenadine—Anaphylactic shock—Methotrexate—lung cancer	0.000119	0.00105	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—lung cancer	0.000119	0.00105	CcSEcCtD
Fexofenadine—Asthenia—Docetaxel—lung cancer	0.000118	0.00104	CcSEcCtD
Fexofenadine—Infection—Methotrexate—lung cancer	0.000118	0.00104	CcSEcCtD
Fexofenadine—Nausea—Etoposide—lung cancer	0.000118	0.00104	CcSEcCtD
Fexofenadine—Pruritus—Docetaxel—lung cancer	0.000117	0.00103	CcSEcCtD
Fexofenadine—Fentanyl—ABCB1—lung cancer	0.000116	0.0552	CrCbGaD
Fexofenadine—Agitation—Doxorubicin—lung cancer	0.000116	0.00102	CcSEcCtD
Fexofenadine—Nausea—Paclitaxel—lung cancer	0.000115	0.00102	CcSEcCtD
Fexofenadine—Diarrhoea—Docetaxel—lung cancer	0.000113	0.000993	CcSEcCtD
Fexofenadine—Loperamide—ABCB1—lung cancer	0.000112	0.0531	CrCbGaD
Fexofenadine—Palpitations—Doxorubicin—lung cancer	0.000111	0.000981	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—lung cancer	0.00011	0.000969	CcSEcCtD
Fexofenadine—Dizziness—Docetaxel—lung cancer	0.000109	0.00096	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000108	0.000953	CcSEcCtD
Fexofenadine—Insomnia—Methotrexate—lung cancer	0.000107	0.000946	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—lung cancer	0.000107	0.000945	CcSEcCtD
Fexofenadine—Dyspnoea—Methotrexate—lung cancer	0.000106	0.000933	CcSEcCtD
Fexofenadine—Somnolence—Methotrexate—lung cancer	0.000106	0.00093	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—lung cancer	0.000105	0.000924	CcSEcCtD
Fexofenadine—Vomiting—Docetaxel—lung cancer	0.000105	0.000923	CcSEcCtD
Fexofenadine—Dyspepsia—Methotrexate—lung cancer	0.000104	0.000921	CcSEcCtD
Fexofenadine—Rash—Docetaxel—lung cancer	0.000104	0.000915	CcSEcCtD
Fexofenadine—Dermatitis—Docetaxel—lung cancer	0.000104	0.000914	CcSEcCtD
Fexofenadine—Headache—Docetaxel—lung cancer	0.000103	0.000909	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—lung cancer	0.000103	0.000906	CcSEcCtD
Fexofenadine—Fatigue—Methotrexate—lung cancer	0.000102	0.000902	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—lung cancer	0.000102	0.0009	CcSEcCtD
Fexofenadine—Pain—Methotrexate—lung cancer	0.000102	0.000895	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—lung cancer	0.0001	0.000884	CcSEcCtD
Fexofenadine—Nausea—Docetaxel—lung cancer	9.78e-05	0.000862	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Methotrexate—lung cancer	9.71e-05	0.000856	CcSEcCtD
Fexofenadine—Urticaria—Methotrexate—lung cancer	9.43e-05	0.000831	CcSEcCtD
Fexofenadine—Body temperature increased—Methotrexate—lung cancer	9.38e-05	0.000827	CcSEcCtD
Fexofenadine—Abdominal pain—Methotrexate—lung cancer	9.38e-05	0.000827	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.37e-05	0.000825	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—lung cancer	9.3e-05	0.000819	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—lung cancer	9.16e-05	0.000808	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—lung cancer	9.14e-05	0.000805	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—lung cancer	9.05e-05	0.000797	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—lung cancer	8.86e-05	0.000781	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—lung cancer	8.79e-05	0.000775	CcSEcCtD
Fexofenadine—Hypersensitivity—Methotrexate—lung cancer	8.75e-05	0.000771	CcSEcCtD
Fexofenadine—Asthenia—Methotrexate—lung cancer	8.52e-05	0.000751	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—lung cancer	8.41e-05	0.000741	CcSEcCtD
Fexofenadine—Pruritus—Methotrexate—lung cancer	8.4e-05	0.00074	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—lung cancer	8.17e-05	0.00072	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—lung cancer	8.13e-05	0.000716	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—lung cancer	8.13e-05	0.000716	CcSEcCtD
Fexofenadine—Diarrhoea—Methotrexate—lung cancer	8.12e-05	0.000716	CcSEcCtD
Fexofenadine—Methadone—ABCB1—lung cancer	7.98e-05	0.0378	CrCbGaD
Fexofenadine—Dizziness—Methotrexate—lung cancer	7.85e-05	0.000692	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—lung cancer	7.57e-05	0.000667	CcSEcCtD
Fexofenadine—Vomiting—Methotrexate—lung cancer	7.55e-05	0.000665	CcSEcCtD
Fexofenadine—Rash—Methotrexate—lung cancer	7.48e-05	0.00066	CcSEcCtD
Fexofenadine—Dermatitis—Methotrexate—lung cancer	7.48e-05	0.000659	CcSEcCtD
Fexofenadine—Headache—Methotrexate—lung cancer	7.44e-05	0.000655	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—lung cancer	7.38e-05	0.00065	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—lung cancer	7.27e-05	0.000641	CcSEcCtD
Fexofenadine—Nausea—Methotrexate—lung cancer	7.05e-05	0.000621	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—lung cancer	7.03e-05	0.00062	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—lung cancer	6.8e-05	0.000599	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—lung cancer	6.54e-05	0.000576	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—lung cancer	6.48e-05	0.000571	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—lung cancer	6.48e-05	0.000571	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—lung cancer	6.44e-05	0.000568	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—lung cancer	6.11e-05	0.000538	CcSEcCtD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.73e-05	0.000246	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.73e-05	0.000246	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2A7—lung cancer	1.72e-05	0.000245	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	1.7e-05	0.000242	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—RAF1—lung cancer	1.7e-05	0.000242	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CAT—lung cancer	1.69e-05	0.000241	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SDC4—lung cancer	1.69e-05	0.00024	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.68e-05	0.00024	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.68e-05	0.000239	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GNG11—lung cancer	1.67e-05	0.000237	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APOA1—lung cancer	1.65e-05	0.000235	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ABCB1—lung cancer	1.65e-05	0.000234	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—lung cancer	1.64e-05	0.000233	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AVP—lung cancer	1.63e-05	0.000233	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.63e-05	0.000233	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	1.63e-05	0.000232	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—RRM1—lung cancer	1.63e-05	0.000232	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA3—lung cancer	1.63e-05	0.000232	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TYMS—lung cancer	1.62e-05	0.00023	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—STK11—lung cancer	1.61e-05	0.000229	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTM1—lung cancer	1.6e-05	0.000227	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFC—lung cancer	1.59e-05	0.000226	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.58e-05	0.000225	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.55e-05	0.000221	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.55e-05	0.00022	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—RRM1—lung cancer	1.54e-05	0.000219	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA3—lung cancer	1.54e-05	0.000219	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—B4GALT5—lung cancer	1.53e-05	0.000218	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP1A1—lung cancer	1.52e-05	0.000216	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CG—lung cancer	1.51e-05	0.000215	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.51e-05	0.000215	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.5e-05	0.000214	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ERCC2—lung cancer	1.5e-05	0.000214	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADCY1—lung cancer	1.5e-05	0.000213	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA4—lung cancer	1.49e-05	0.000212	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTP1—lung cancer	1.49e-05	0.000212	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.47e-05	0.000209	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPP2R1B—lung cancer	1.46e-05	0.000208	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SMARCA4—lung cancer	1.46e-05	0.000208	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA2—lung cancer	1.45e-05	0.000207	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAT—lung cancer	1.45e-05	0.000206	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—B4GALT5—lung cancer	1.44e-05	0.000205	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.44e-05	0.000205	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—POMC—lung cancer	1.44e-05	0.000205	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HSPB1—lung cancer	1.41e-05	0.0002	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ABCB1—lung cancer	1.41e-05	0.0002	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA4—lung cancer	1.4e-05	0.0002	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA1—lung cancer	1.4e-05	0.000199	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CREBBP—lung cancer	1.4e-05	0.000199	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTHLH—lung cancer	1.39e-05	0.000198	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.39e-05	0.000198	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCC3—lung cancer	1.39e-05	0.000197	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TYMS—lung cancer	1.38e-05	0.000197	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA2—lung cancer	1.37e-05	0.000195	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—lung cancer	1.37e-05	0.000195	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKR1C1—lung cancer	1.34e-05	0.000191	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CD—lung cancer	1.33e-05	0.000189	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA1—lung cancer	1.32e-05	0.000188	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—lung cancer	1.31e-05	0.000187	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ANXA1—lung cancer	1.31e-05	0.000186	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCC3—lung cancer	1.31e-05	0.000186	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—UGT1A1—lung cancer	1.3e-05	0.000185	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOA1—lung cancer	1.3e-05	0.000185	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP1A1—lung cancer	1.3e-05	0.000184	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ERCC2—lung cancer	1.29e-05	0.000183	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.28e-05	0.000182	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FLT1—lung cancer	1.27e-05	0.00018	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKR1C1—lung cancer	1.26e-05	0.00018	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	1.26e-05	0.000179	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GNG11—lung cancer	1.26e-05	0.000179	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.24e-05	0.000177	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APP—lung cancer	1.24e-05	0.000177	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH3—lung cancer	1.24e-05	0.000177	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.23e-05	0.000176	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF9—lung cancer	1.23e-05	0.000175	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—UGT1A1—lung cancer	1.23e-05	0.000175	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDOA—lung cancer	1.2e-05	0.00017	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—POMC—lung cancer	1.2e-05	0.00017	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.19e-05	0.000169	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—lung cancer	1.19e-05	0.000169	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GNG11—lung cancer	1.18e-05	0.000168	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JUNB—lung cancer	1.18e-05	0.000167	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA3—lung cancer	1.16e-05	0.000165	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—lung cancer	1.16e-05	0.000165	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—lung cancer	1.15e-05	0.000163	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	1.14e-05	0.000162	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—POMC—lung cancer	1.13e-05	0.000161	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ADCY1—lung cancer	1.13e-05	0.000161	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCG2—lung cancer	1.13e-05	0.000161	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDOA—lung cancer	1.13e-05	0.00016	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOA1—lung cancer	1.11e-05	0.000158	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HPGDS—lung cancer	1.11e-05	0.000158	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ENO2—lung cancer	1.11e-05	0.000158	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	1.1e-05	0.000157	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPP2R1B—lung cancer	1.1e-05	0.000157	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CREBBP—lung cancer	1.1e-05	0.000157	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA3—lung cancer	1.09e-05	0.000156	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—POMC—lung cancer	1.09e-05	0.000155	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—lung cancer	1.07e-05	0.000153	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STK11—lung cancer	1.07e-05	0.000152	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.06e-05	0.000152	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ADCY1—lung cancer	1.06e-05	0.000151	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCG2—lung cancer	1.06e-05	0.000151	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2A6—lung cancer	1.06e-05	0.000151	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCLC—lung cancer	1.06e-05	0.000151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6R—lung cancer	1.06e-05	0.000151	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HPGDS—lung cancer	1.04e-05	0.000149	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ENO2—lung cancer	1.04e-05	0.000149	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—lung cancer	1.04e-05	0.000148	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.04e-05	0.000148	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.04e-05	0.000148	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FOXO3—lung cancer	1.03e-05	0.000147	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—lung cancer	1.03e-05	0.000147	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—lung cancer	1.01e-05	0.000144	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—lung cancer	1.01e-05	0.000144	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	1.01e-05	0.000144	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ENO1—lung cancer	1.01e-05	0.000143	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.01e-05	0.000143	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	1e-05	0.000143	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2A6—lung cancer	1e-05	0.000142	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCLC—lung cancer	1e-05	0.000142	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTEN—lung cancer	1e-05	0.000142	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—POMC—lung cancer	9.66e-06	0.000137	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AVP—lung cancer	9.65e-06	0.000137	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	9.63e-06	0.000137	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—EP300—lung cancer	9.54e-06	0.000136	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ENO1—lung cancer	9.49e-06	0.000135	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	9.41e-06	0.000134	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CREBBP—lung cancer	9.41e-06	0.000134	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1R—lung cancer	9.29e-06	0.000132	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	9.25e-06	0.000132	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HES1—lung cancer	9.13e-06	0.00013	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—lung cancer	9.09e-06	0.000129	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2E1—lung cancer	9.03e-06	0.000129	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—lung cancer	9.01e-06	0.000128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RAF1—lung cancer	8.95e-06	0.000127	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NQO1—lung cancer	8.93e-06	0.000127	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—lung cancer	8.92e-06	0.000127	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2—lung cancer	8.84e-06	0.000126	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—lung cancer	8.81e-06	0.000125	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	8.74e-06	0.000124	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.51e-06	0.000121	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2E1—lung cancer	8.51e-06	0.000121	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NQO1—lung cancer	8.41e-06	0.00012	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—lung cancer	8.4e-06	0.00012	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB3—lung cancer	8.35e-06	0.000119	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—STK11—lung cancer	8.05e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2—lung cancer	8.03e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—lung cancer	8e-06	0.000114	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTEN—lung cancer	7.86e-06	0.000112	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—lung cancer	7.78e-06	0.000111	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR1—lung cancer	7.77e-06	0.000111	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—lung cancer	7.71e-06	0.00011	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—lung cancer	7.65e-06	0.000109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—STK11—lung cancer	7.58e-06	0.000108	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—EP300—lung cancer	7.49e-06	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—lung cancer	7.45e-06	0.000106	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOA1—lung cancer	7.38e-06	0.000105	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—lung cancer	7.32e-06	0.000104	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAT—lung cancer	7.25e-06	0.000103	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—lung cancer	7.06e-06	0.0001	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—lung cancer	7.02e-06	9.99e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TYMS—lung cancer	6.92e-06	9.85e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—lung cancer	6.84e-06	9.74e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAT—lung cancer	6.83e-06	9.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—lung cancer	6.74e-06	9.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KIT—lung cancer	6.74e-06	9.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APC—lung cancer	6.74e-06	9.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—NRAS—lung cancer	6.74e-06	9.59e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTEN—lung cancer	6.72e-06	9.56e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGF—lung cancer	6.66e-06	9.48e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCB1—lung cancer	6.64e-06	9.45e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TYMS—lung cancer	6.52e-06	9.28e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1A1—lung cancer	6.49e-06	9.23e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK3—lung cancer	6.45e-06	9.18e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—lung cancer	6.45e-06	9.18e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ERCC2—lung cancer	6.43e-06	9.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—POMC—lung cancer	6.41e-06	9.13e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—EP300—lung cancer	6.41e-06	9.12e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BRAF—lung cancer	6.33e-06	9.01e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6R—lung cancer	6.26e-06	8.91e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CREBBP—lung cancer	6.25e-06	8.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—lung cancer	6.14e-06	8.74e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1A1—lung cancer	6.11e-06	8.7e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ERCC2—lung cancer	6.06e-06	8.63e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAP2K1—lung cancer	5.96e-06	8.49e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—lung cancer	5.92e-06	8.43e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	5.87e-06	8.35e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—lung cancer	5.8e-06	8.25e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—lung cancer	5.76e-06	8.2e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA1—lung cancer	5.57e-06	7.92e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—lung cancer	5.54e-06	7.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	5.33e-06	7.58e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MDM2—lung cancer	5.31e-06	7.55e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAF1—lung cancer	5.29e-06	7.53e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA1—lung cancer	5.24e-06	7.46e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB2—lung cancer	5.23e-06	7.45e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MTOR—lung cancer	5.16e-06	7.35e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—lung cancer	5.16e-06	7.35e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—lung cancer	5.08e-06	7.23e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—lung cancer	4.96e-06	7.06e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRAS—lung cancer	4.93e-06	7.02e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—POMC—lung cancer	4.84e-06	6.88e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—lung cancer	4.79e-06	6.82e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—lung cancer	4.79e-06	6.81e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—lung cancer	4.75e-06	6.76e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2—lung cancer	4.74e-06	6.75e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—lung cancer	4.74e-06	6.75e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—lung cancer	4.72e-06	6.72e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CREBBP—lung cancer	4.71e-06	6.7e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—lung cancer	4.62e-06	6.58e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JUN—lung cancer	4.61e-06	6.57e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—POMC—lung cancer	4.56e-06	6.49e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—lung cancer	4.53e-06	6.45e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—lung cancer	4.49e-06	6.39e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1A—lung cancer	4.47e-06	6.36e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—lung cancer	4.47e-06	6.36e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTEN—lung cancer	4.46e-06	6.35e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CREBBP—lung cancer	4.44e-06	6.32e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—lung cancer	4.41e-06	6.28e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—lung cancer	4.35e-06	6.2e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EP300—lung cancer	4.26e-06	6.06e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—lung cancer	4.21e-06	5.99e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—lung cancer	4.16e-06	5.91e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SRC—lung cancer	4.14e-06	5.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—lung cancer	4.03e-06	5.74e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—lung cancer	3.99e-06	5.68e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NRAS—lung cancer	3.98e-06	5.67e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—lung cancer	3.89e-06	5.54e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—lung cancer	3.87e-06	5.51e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—lung cancer	3.86e-06	5.49e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK3—lung cancer	3.81e-06	5.43e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—lung cancer	3.71e-06	5.28e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—lung cancer	3.67e-06	5.22e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—lung cancer	3.64e-06	5.17e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—lung cancer	3.63e-06	5.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—lung cancer	3.43e-06	4.88e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTEN—lung cancer	3.36e-06	4.79e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—EP300—lung cancer	3.21e-06	4.57e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTEN—lung cancer	3.17e-06	4.51e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.15e-06	4.48e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—lung cancer	3.05e-06	4.33e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—EP300—lung cancer	3.02e-06	4.3e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRAS—lung cancer	2.91e-06	4.14e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—lung cancer	2.79e-06	3.97e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—lung cancer	2.57e-06	3.66e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—lung cancer	2.37e-06	3.38e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.24e-06	3.18e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—lung cancer	1.94e-06	2.76e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—lung cancer	1.83e-06	2.6e-05	CbGpPWpGaD
